Biomeme and Indical enters into an exclusive global licensing and research agreement in a joint effort to improve animal health globally.

Biomeme has developed an advanced mobile PCR detection technology that solves time-sensitive and location-sensitive problems where results need to be in real-time. Indical, with twenty years of experience animal diagnostics, will adapt the molecular point-of-need testing for veterinary applications and offer its suite of molecular and immunological testing solutions.